Skip to content

Tag Archives: harm-reduction

Addiction to nicotine trumps even lung cancer

Unfortunately, harm reduction approaches have yet to be widely accepted for those addicted to cigarettes. A new study by the American Cancer Society illustrates the depth of this addiction and the difficulty some smokers face even when a diagnosis of cancer makes it imperative that they quit. One woman, a smoker whose cancerous lung was removed, explained in an MSNBC interview the draw of cigarettes despite the litany of cessation methods she tried.

Injecting drug use via femoral vein puncture: Preliminary findings of a point-of-care ultrasound service for opioid-dependent groin injectors in…

Background: Within the UK, injecting in the femoral vein (FV), often called ‘groin injecting’, is a serious cause of risk and harm. This study aimed to use ultrasound scanning as a means to engage groin injectors (GIs), examine their femoral injecting sites and assess their venous health, with the intention of developing improved responses. Methods: Between September 2006 and March 2009, GIs attending a network of community drug treatment centres in South East England were invited to attend an ultrasound ‘health-check’ clinic.

Implementation and Evaluation of a Harm-Reduction Model for Clinical Care of Substance Using Pregnant Women

Background: Methamphetamine (MA) use during pregnancy is associated with many pregnancy complications, including preterm birth, small for gestational age, preeclampsia, and abruption. Hawaii has lead the nation in MA use for many years, yet prior to 2007, did not have a comprehensive plan to care for pregnant substance-using women. In 2006, the Hawaii State Legislature funded a pilot perinatal addiction clinic

Prescribing Cannabis for Harm Reduction

Neuropathic pain affects between 5% and 10% of the US population and can be refractory to treatment.

Study Shows that E-Cigarettes are Safer than Smoking Tobacco: PrimeVapor reports that a researcher from Boston University has shown that Electronic…

PrimeVapor wants smokers to know that there is now a choice between quitting and smoking. Dr. Micheal Siegel is a professor at Boston University

E-Cigarettes are the Future of Smoking in America : It doesn’t take a rocket scientist to see the differences between regular tobacco cigarettes and…

There is a different way to get that hit of nicotine without hurting yourself and those around you according to prominent harm reduction specialists like Bill Godshall of Smoke Free Pennsylvania. It’s called an e-cigarette and it is the future of smoking in America

22nd Century Group Announces Initial Results of Smoking Cessation Trial : Results will help determine the optimal nicotine content for X-22

22nd Century Group, Inc. (OTCBB: XXII), a company focused on smoking cessation and tobacco harm reduction products, today announced X-22, a prescription smoking cessation aid in development consisting of very low nicotine (VLN) cigarettes, showed a reduction of smoking from baseline over the 6-week treatment period in the company’s Phase II-B clinical trial

Harm reduction interventions for drug injectors or heroin users in Spain: expanding coverage as the storm abates

ABSTRACT Aims:  To show the utility of analyzing time trends of need and coverage of needle-exchange programs (NEPs) and opioid substitution treatment (OST) to assess harm reduction policies targeting drug injectors or heroin users. Design:  Multiple methods applied to secondary data. Setting:  Spain

SIPS brief interventions findings conference: 5th March 2012, King’s College London

Results from the UK's largest brief intervention study, the SIPS trial , will be officialy released at a conference on Monday 5th March 2012, Institute of Psychiatry, King's College London. Download the flyer for Alcohol Screening and Brief Interventions: From Research into Practice [pdf]. The event is a one day conference including the launch of SIPS Junior, a new trial into brief interventions for adolescents.

Venous access and care: Harnessing pragmatics in harm reduction for people who inject drugs

Abstract Aim:  To explore the facilitators of long-term hepatitis C avoidance among people who inject drugs. Design:  We employed a qualitative life history design